Zentalis Pharmaceuticals ...

1.92
-0.15 (-7.25%)
At close: Mar 03, 2025, 3:59 PM
1.86
-3.03%
After-hours: Mar 03, 2025, 04:09 PM EST

Zentalis Pharmaceuticals Balance Sheet Statement

Year FY23 FY22 FY21 FY20 FY19 FY18
Cash & Equivalents 28.04M 43.07M 59.71M 54.95M 82.42M 25.15M
Short-Term Investments 454.88M 394.3M 280.17M 283.55M n/a n/a
Long-Term Investments n/a 21.21M 37.49M 1.32M 243K -46.26K
Other Long-Term Assets 9.5M -1.8M 2.63M 2.34M 2.22M 1.52M
Receivables n/a n/a 2.63M 417K 140K 917K
Inventory n/a -7.04M -4.44M n/a n/a n/a
Other Current Assets 13.8M 29.12M 8.01M 11.19M 1.5M 606K
Total Current Assets 496.72M 451.93M 350.77M 345.1M 84.07M 26.68M
Property-Plant & Equipment 41.73M 50.08M 52.84M 3.62M 2.84M 260K
Goodwill & Intangibles 3.74M 3.74M 3.74M 12.54M 12.54M 12.54M
Total Long-Term Assets 54.97M 87.38M 103.74M 20.45M 18.59M 14.32M
Total Assets 551.69M 539.31M 454.51M 365.56M 102.66M 41M
Account Payables 14.93M 11.25M 11.59M 8.66M 4.29M 3.43M
Deferred Revenue n/a -2.16M n/a n/a n/a 223.42K
Short-Term Debt n/a n/a 1.45M 902K 781K n/a
Other Current Liabilities 54.16M 45.4M 29.93M 18.63M 9.83M 2.78M
Total Current Liabilities 69.37M 56.65M 43.94M 28.6M 14.9M 6.21M
Long-Term Debt 43.15M 90.33M 88.92M 1.1M n/a n/a
Other Long-Term Liabilities 1.78M -42.55M -44.46M n/a 949K 21K
Total Long-Term Liabilities 44.93M 48.64M 46.08M 3.58M 4.16M 2.48M
Total Liabilities 114.3M 105.29M 90.03M 32.18M 19.06M 8.69M
Total Debt 43.15M 45.17M 45.91M 2M 781K n/a
Common Stock 70K 59K 45K 41K 25K 2.27M
Retained Earnings -888.56M -596.37M -359.56M -200.83M -82.99M -37.33M
Comprehensive Income 2.19M -1.35M -125K 36K -141.71M -56K
Shareholders Equity 437.28M 434.02M 364.48M 333.38M 76.78M 24.77M
Total Investments 454.88M 415.51M 317.67M 283.55M 243K -46.26K